Polaprezinc is a chelated form of zinc and L-carnosine. It is a zinc-related medicine approved for the first time in Japan, which has been clinically used to treat gastric ulcers . It was determined that polaprezinc may be effective in pressure ulcer treatment . A study in 2013 showed that CO-administration of polaprezinc may be effective against small intestine mucosal injury associated with long-term aspirin therapy .
Peptic ulcer disease, dyspepsia .
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.